COVID-19: Tokyo Medical University predicts aggravation of blood particles: “exosomes”
COVID-19: Eisai to jointly develop therapeutic drug: Utilization of Eritoran and E6011
Shimadzu: Reduced 15-minute work to 5 minutes: Clinical laboratory / analyzer